CP
EVOJU

Covalent Partners’s Evo Acquisition Corp. Unit EVOJU Stock Holding History

Covalent Partners’s Portfolio EVOJU Stock Details EVOJU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100,000
Closed -$993K – 63
2021
Q1 		$993K Buy
+100,000
New +$1.01M 1.73% 23

Other funds holding EVOJU

FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.44% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Ramius Advisors New York $95.2M AUM 7.33% 1-Year Est. Return

Covalent Partners's EVOJU Position: Q2 2021 in Review

Covalent Partners sold out of Evo Acquisition Corp. Unit (EVOJU) in Q2 2021, closing a stake of 100,000 shares — an estimated $993K sold.

Covalent Partners first reported a position in EVOJU in Q1 2021 and held it in 1 quarter. The position peaked at $993K in Q1 2021. 29 funds tracked by Wall St. Rank hold EVOJU as of Q2 2021.

  • Covalent Partners reported no remaining Evo Acquisition Corp. Unit position as of Q2 2021 after selling out during the quarter.
  • Covalent Partners sold 100,000 Evo Acquisition Corp. Unit shares in Q2 2021, an estimated $993K.
  • Covalent Partners first reported a position in Evo Acquisition Corp. Unit in Q1 2021 and held it in 1 quarter.
  • Covalent Partners's Evo Acquisition Corp. Unit position peaked at $993K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Evo Acquisition Corp. Unit as of Q2 2021.

Based on Covalent Partners's 13F filing for Q2 2021, filed 16 Aug 2021.